SCHEMBL4264844

SCHEMBL4264844

O=C(O)c1noc2c1CN(C(=O)C=Cc1ccccc1)CC2

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 5/20 0.49
KMT2A Q03164 3/20 0.48
MEN1 O00255 2/20 0.48
POLB P06746 1/20 0.46
MAPT P10636 4/20 0.46
HPGD P15428 4/20 0.46
NPC1 O15118 4/20 0.46
HTT P42858 2/20 0.43
LMNA P02545 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
KDM4E B2RXH2 1/20 0.43
MAPK1 P28482 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
ME2 P23368 1/20 0.42
ME1 P48163 1/20 0.42
ME3 Q16798 1/20 0.42
GAA P10253 2/20 0.41
AR P10275 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4264840 1.00 RAB9A (0.49) RAB9AKMT2AMEN1POLBMAPT
SCHEMBL2590810 0.84 HSP90AA1 (0.53) RAB9AKMT2AMEN1MAPTHPGD
SCHEMBL5532889 0.83 RAB9A (0.46) RAB9AKMT2AMEN1POLBMAPT
SCHEMBL2585600 0.81 HSP90AA1 (0.45) RAB9AKMT2AMEN1POLBMAPT
SCHEMBL2585492 0.76 MAPT (0.53) RAB9AKMT2AMEN1POLBMAPT
SCHEMBL5530113 0.75 RAB9A (0.41) RAB9AKMT2AMEN1POLBMAPT
SCHEMBL3099503 0.74 LMNA (0.53) RAB9AKMT2AHPGDNPC1HTT
SCHEMBL4267581 0.74 KMT2A (0.52) RAB9AKMT2AMEN1POLBMAPT
SCHEMBL4274149 0.73 ALDH1A1 (0.48) RAB9AKMT2APOLBMAPTNPC1
SCHEMBL4262082 0.73 LMNA (0.49) RAB9AKMT2AMEN1POLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1869053-B1 SUBSTITUTED 4,5,6,7-TETRAHYDRO-ISOXAZOLO[4,5-C]PYRIDINE COMPOUNDS AND THEIR USE IN THE PRODUCTION OF MEDICAMENTS GRUENENTHAL GMBH (DE) 2013-10-09 EP claimed
US-20090076001-A1 Substituted 4,5,6,7 -Tetrahydro-Isoxazolo[4,5-C]Pyridine Compounds and Use Thereof for Producing Medicaments GRUENENTHAL GMBH (DE) 2009-03-19 US claimed
US-20090076001-A1 Substituted 4,5,6,7 -Tetrahydro-Isoxazolo[4,5-C]Pyridine Compounds and Use Thereof for Producing Medicaments GRUENENTHAL GMBH (DE) 2009-03-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090076001-A1 Substituted 4,5,6,7 -Tetrahydro-Isoxazolo[4,5-C]Pyridine Compounds and Use Thereof for Producing Medicaments P2RX5, P2RX4, P2RX7 RAB9A 4445/4885KMT2A 4073/4885MEN1 2795/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.